Can a new pressure relief mode outperform standard therapy for sleep apnea?

NCT ID NCT07751562

First seen Aug 07, 2026 ยท Last updated Aug 07, 2026

Summary

This study tests whether a new auto-adjusting positive airway pressure (APAP) device with a feature called Kairos PAP (KPAP) works better than a standard APAP device with expiratory pressure relief (EPR) for people with obstructive sleep apnea. Participants, who already use PAP therapy, will try both devices during overnight sleep studies in a random order. Researchers will measure how well each device reduces breathing pauses and improves sleep quality, and participants will share which device they prefer.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Automatic positive airway pressure (APAP) with either Kairos PAP (KPAP) or Expiratory Pressure Relief (EPR)
What this could lead to
If KPAP proves more effective than standard EPR, it could offer a more comfortable and efficient way to manage sleep apnea, potentially improving sleep quality and adherence.
What could go wrong
This is a small crossover study (30 participants), so results may not apply to everyone. Individual responses vary, and the study doesn't measure long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP APNEA, OBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.